Published in Neth J Med on October 01, 2005
The treatment of hematologic malignancies in pregnancy. Facts Views Vis Obgyn (2010) 0.81
Acute lymphoblastic leukemia in pregnancy: a case report with literature review. Ther Adv Hematol (2013) 0.80
A rare case of acute lymphoblastic leukaemia in pregnancy- unique maternal-fetal challenges. J Clin Diagn Res (2014) 0.75
Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS. Ann Intern Med (1993) 7.21
Comparison of CHOP chemotherapy with autologous bone marrow transplantation for slowly responding patients with aggressive non-Hodgkin's lymphoma. N Engl J Med (1995) 6.52
Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol (2007) 6.35
Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry. N Engl J Med (1999) 5.82
HIV-1 biological phenotype in long-term infected individuals evaluated with an MT-2 cocultivation assay. AIDS (1992) 3.91
Low prevalence of methicillin-resistant Staphylococcus aureus (MRSA) at hospital admission in the Netherlands: the value of search and destroy and restrictive antibiotic use. J Hosp Infect (2004) 3.69
An antibiotic policy to prevent emergence of resistant bacilli. Lancet (2000) 3.56
Rapid identification and antimicrobial susceptibility testing reduce antibiotic use and accelerate pathogen-directed antibiotic use. J Antimicrob Chemother (2007) 2.62
Identification of Burkholderia spp. in the clinical microbiology laboratory: comparison of conventional and molecular methods. J Clin Microbiol (1999) 2.36
The granularity of medical narratives and its effect on the speed and completeness of information retrieval. J Am Med Inform Assoc (1998) 2.03
Medical narratives in electronic medical records. Int J Med Inform (1997) 1.88
Circulating tumour cells early predict progression-free and overall survival in advanced colorectal cancer patients treated with chemotherapy and targeted agents. Ann Oncol (2009) 1.87
Age-specific differences in the diagnostics and treatment of cancer patients aged 50 years and older in the province of Limburg, The Netherlands. Ann Oncol (1996) 1.76
Improved detection of methicillin-resistant Staphylococcus aureus using phenyl mannitol broth containing aztreonam and ceftizoxime. J Clin Microbiol (2001) 1.71
Occurrence of yeast bloodstream infections between 1987 and 1995 in five Dutch university hospitals. Eur J Clin Microbiol Infect Dis (1996) 1.60
Pitfalls and fallacies of cat scratch disease serology: evaluation of Bartonella henselae-based indirect fluorescence assay and enzyme-linked immunoassay. J Clin Microbiol (1997) 1.48
Letter to the editor: seafarers: a new risk group for meticillin-resistant Staphylococcus aureus (MRSA). Euro Surveill (2013) 1.47
Viridans streptococci isolated from the bloodstream. Relevance of species identification. Diagn Microbiol Infect Dis (1995) 1.46
A qualitative exploration of reasons for poor hand hygiene among hospital workers: lack of positive role models and of convincing evidence that hand hygiene prevents cross-infection. Infect Control Hosp Epidemiol (2009) 1.44
Home care versus hospital care of patients with hematological malignancies and chemotherapy-induced cytopenia. Ann Oncol (2005) 1.41
Thrombotic and infectious complications of central venous catheters in patients with hematological malignancies. Ann Oncol (2007) 1.41
Interferon treatment of refractory idiopathic thrombocytopenic purpura (ITP) Eur J Haematol (1994) 1.39
Multidrug resistance mediated by P-glycoprotein in haematological malignancies. Neth J Med (1993) 1.38
Incidence, survival and prevalence of myeloid malignancies in Europe. Eur J Cancer (2012) 1.32
Transmission of methicillin-resistant Staphylococcus aureus to household contacts. J Clin Microbiol (2009) 1.27
Evaluation of four selective agars and two enrichment broths in screening for methicillin-resistant Staphylococcus aureus. J Clin Microbiol (2008) 1.26
MIB-1 labelling index is an independent prognostic marker in primary breast cancer. Br J Cancer (1998) 1.21
Rapid emergence of ciprofloxacin-resistant enterobacteriaceae containing multiple gentamicin resistance-associated integrons in a Dutch hospital. Emerg Infect Dis (2001) 1.19
Outbreak of severe sepsis due to contaminated propofol: lessons to learn. J Hosp Infect (2010) 1.16
Sustained low prevalence of meticillin-resistant Staphylococcus aureus upon admission to hospital in The Netherlands. J Hosp Infect (2011) 1.15
Pneumonia due to Micrococcus spp. in a patient with acute myeloid leukaemia. Leukemia (1992) 1.15
Emergence of MRSA of unknown origin in the Netherlands. Clin Microbiol Infect (2011) 1.12
Dose-dense epirubicin and paclitaxel with G-CSF: a study of decreasing intervals in metastatic breast cancer. Br J Cancer (2000) 1.11
Prevalence and course of fatigue in breast cancer patients receiving adjuvant chemotherapy. Ann Oncol (2004) 1.10
Immediate incubation of blood cultures outside routine laboratory hours of operation accelerates antibiotic switching. J Clin Microbiol (2009) 1.10
Urinary tract infections with Aerococcus urinae in the south of The Netherlands. Eur J Clin Microbiol Infect Dis (1997) 1.09
Proof of principle for successful characterization of methicillin-resistant coagulase-negative staphylococci isolated from skin by use of Raman spectroscopy and pulsed-field gel electrophoresis. J Clin Microbiol (2009) 1.04
Value of different modalities of granulocyte-macrophage colony-stimulating factor applied during or after induction therapy of acute myeloid leukemia. J Clin Oncol (1997) 1.04
Normal hospital and low-bacterial diet in patients with cytopenia after intensive chemotherapy for hematological malignancy: a study of safety. Ann Oncol (2007) 0.96
Course of mental fatigue and motivation in breast cancer patients receiving adjuvant chemotherapy. Ann Oncol (2005) 0.96
Clinical significance of bacteriologic screening in platelet concentrates. Transfusion (2005) 0.95
Vincristine, doxorubicin and dexamethasone (VAD) administered as rapid intravenous infusion for first-line treatment in untreated multiple myeloma. Br J Haematol (1999) 0.93
Myeloproliferative neoplasia: a review of clinical criteria and treatment. Neth J Med (2012) 0.92
Gastric low-grade MALT lymphoma, high-grade MALT lymphoma and diffuse large B cell lymphoma show different frequencies of trisomy. Leukemia (1999) 0.92
Improving hand hygiene behaviour of nurses using action planning: a pilot study in the intensive care unit and surgical ward. J Hosp Infect (2010) 0.91
Successful treatment for carriage of methicillin-resistant Staphylococcus aureus and importance of follow-up. Antimicrob Agents Chemother (2010) 0.91
Effects of medroxyprogesterone acetate on appetite, weight, and quality of life in advanced-stage non-hormone-sensitive cancer: a placebo-controlled multicenter study. J Clin Oncol (1996) 0.91
Accuracy of identification and susceptibility results by direct inoculation of Vitek 2 cards from positive BACTEC cultures. Eur J Clin Microbiol Infect Dis (2004) 0.90
Two sides of the medallion: poor treatment tolerance but better survival by standard chemotherapy in elderly patients with advanced-stage diffuse large B-cell lymphoma. Ann Oncol (2011) 0.88
Comparison of A and B-type lamin expression in reactive lymph nodes and nodular sclerosing Hodgkin's disease. Histopathology (1997) 0.88
CD44v6 is not a prognostic factor in primary breast cancer. Ann Oncol (1998) 0.87
Invasive aspergillosis in immunocompromised patients: findings on plain film and (HR)CT. Eur J Radiol (1992) 0.87
Intensive chemotherapy to improve outcome in patients with acute lymphoblastic leukemia over the age of 40: a phase II study for efficacy and feasibility by HOVON. Leukemia (2012) 0.86
Use of surgical-site infection rates to rank hospital performance across several types of surgery. Br J Surg (2013) 0.86
Comparative study of dose escalation versus interval reduction to obtain dose-intensification of epirubicin and cyclophosphamide with granulocyte colony-stimulating factor in advanced breast cancer. J Clin Oncol (1997) 0.85
Dutch guideline on the laboratory detection of methicillin-resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis (2013) 0.85
Peripheral blood stem cell transplantation as an alternative to autologous marrow transplantation in the treatment of acute myeloid leukemia? Bone Marrow Transplant (1999) 0.84
Frequency of microbiologically correct antibiotic therapy increased by infectious disease consultations and microbiological results. J Clin Microbiol (2012) 0.84
Good performance of the SpectraCellRA system for typing of methicillin-resistant Staphylococcus aureus isolates. J Clin Microbiol (2013) 0.84
Adjuvant chemohormonal therapy with cyclophosphamide, doxorubicin and 5-fluorouracil (CAF) with or without medroxyprogesterone acetate for node-positive breast cancer patients. Ann Oncol (1993) 0.83
Needle-to-incubator transport time: logistic factors influencing transport time for blood culture specimens. J Clin Microbiol (2009) 0.83
[Optimisation of the antibiotic policy in the Netherlands. XII. The SWAB guideline for antimicrobial eradication of MRSA in carriers]. Ned Tijdschr Geneeskd (2008) 0.83
Myelodysplasia presenting with pulmonary manifestations associated with neutrophilic dermatosis. Ann Hematol (1998) 0.83
Quality of life more impaired in younger than in older diffuse large B cell lymphoma survivors compared to a normative population: a study from the population-based PROFILES registry. Ann Hematol (2013) 0.82
Keratinocyte growth factor ameliorates acute graft-versus-host disease in a novel nonmyeloablative haploidentical transplantation model. Bone Marrow Transplant (2005) 0.81
Adnexal masses in pregnancy. Onkologie (2003) 0.81
Laying-up of sterile instruments in the operating theatre: equal or superior protection by using a horizontal unidirectional air flow system. J Hosp Infect (2013) 0.80
Short intensive sequential therapy followed by autologous stem cell transplantation in adult Burkitt, Burkitt-like and lymphoblastic lymphoma. Leukemia (2005) 0.80
Morphologically normal, CD30-negative B-lymphocytes with chromosome aberrations in classical Hodgkin's disease: the progenitor cell of the malignant clone? J Pathol (1999) 0.80
Clinical practices concerning central venous catheters in haematological patients. Eur J Oncol Nurs (2010) 0.79
Transmission of hepatitis B virus among heart transplant recipients during endomyocardial biopsy procedures. J Heart Lung Transplant (1998) 0.79
Proliferation and apoptosis in primary gastric B-cell non-Hodgkin's lymphoma. Histopathology (1997) 0.79
"Downhill" oesophagus varices: a clue to a serious disease. Neth J Med (1992) 0.79
Expression of CD10, CD75 and CD43 in MALT lymphoma and their usefulness in discriminating MALT lymphoma from follicular lymphoma and chronic gastritis. Histopathology (1999) 0.79
Hospital and community acquired infection and the built environment--design and testing of infection control rooms. J Hosp Infect (2007) 0.79
Comorbidity and treatment decision-making in elderly non-Hodgkin's lymphoma patients: a survey among haematologists. Neth J Med (2014) 0.79
Relevance of the expression of bcl-2 in combination with p53 as a prognostic factor in breast cancer. Anticancer Res (1999) 0.79
High-vs low-dose cytarabine combined with interferon alfa in patients with first chronic phase chronic myeloid leukemia. A prospective randomized phase III study. Ann Hematol (2006) 0.79
Home treatment for intensive hematological therapies: who will benefit? Ann Oncol (2006) 0.78
Inactivation of human immunodeficiency virus by gamma radiation and its effect on plasma and coagulation factors. Transfusion (1991) 0.78
Rapid identification of Staphyloccocus aureus in positive-testing blood cultures by Slidex Staph Plus agglutination test. J Clin Microbiol (2007) 0.78
The prognostic significance of steroid receptor activity in tumor tissues of patients with primary breast cancer. Am J Clin Oncol (1997) 0.78
Drug clearance by continuous haemodiafiltration. Analysis of sieving coefficients and mass transfer coefficients of diffusion. Blood Purif (1993) 0.78
Factors that influence treatment decision-making in elderly DLBCL patients: a case vignette study. Ann Hematol (2015) 0.78
The effect of optimal treatment on elderly patients with aggressive non-Hodgkin's lymphoma: more patients treated with unaffected response rates. Ann Hematol (2001) 0.77
Epirubicin and paclitaxel with G-CSF support in first line metastatic breast cancer: a randomized phase II study of dose-dense and dose-escalated chemotherapy. Breast Cancer Res Treat (2011) 0.77
Temporal relationship between HHV 6 and graft vs host disease in a patient after haplo-identical SCT and severe T-cell depletion. Bone Marrow Transplant (2010) 0.77
Concentrated citrate locking in order to reduce the long-term complications of central venous catheters: a randomized controlled trial in patients with hematological malignancies. Support Care Cancer (2014) 0.77
Cell turnover parameters in small and large cell varieties of primary intestinal non-Hodgkin's lymphoma. Cancer (1998) 0.77
Chromosomal abnormalities in Hodgkin's disease are not restricted to Hodgkin/Reed-Sternberg cells. J Pathol (1998) 0.77
The use of thalidomide in chronic refractory graft versus host disease. Neth J Med (2001) 0.77
Treatment of elderly patients with intermediate- and high-grade non-Hodgkin's lymphoma: a retrospective population-based study. Ann Hematol (2001) 0.77
Prosthetic hip-joint infection due to Listeria monocytogenes. Clin Infect Dis (1995) 0.76
Proteolysis of human apolipoprotein B: effect on quantitative immunoturbidimetry. Clin Chim Acta (1990) 0.76
Intensive postremission chemotherapy without maintenance therapy in adults with acute lymphoblastic leukemia. Dutch Hemato-Oncology Research Group. J Clin Oncol (1997) 0.76
pS2 is an independent prognostic factor for post-relapse survival in primary breast cancer. Anticancer Res (1998) 0.76
HLA-matched allo-SCT after reduced intensity conditioning with fludarabine/CY in patients with metastatic breast cancer. Bone Marrow Transplant (2009) 0.76
Complex chromosome 9, 20, and 22 rearrangements in acute lymphoblastic leukemia with duplication of BCR and ABL sequences. Cancer Genet Cytogenet (2000) 0.76